Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elevating the Standard of Care for Patients with Axial Spondyloarthritis: 'Calls to Action' from Rheumacensus, a Multistakeholder Pan-European Initiative.
Phoka A, van den Bemt BJF, Lubrano E, Singh I, Fernández-Carballido C, Parow D, Webb D, Lacombe F, Harrington L, Baraliakos X. Phoka A, et al. Among authors: van den bemt bjf. Rheumatol Ther. 2024 Jun;11(3):773-794. doi: 10.1007/s40744-024-00663-4. Epub 2024 Apr 25. Rheumatol Ther. 2024. PMID: 38662146 Free PMC article.
Open-Label, Non-Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: Six-Month Results From a Controlled Cohort Study.
Tweehuysen L, Huiskes VJB, van den Bemt BJF, Vriezekolk JE, Teerenstra S, van den Hoogen FHJ, van den Ende CH, den Broeder AA. Tweehuysen L, et al. Among authors: van den hoogen fhj, van den bemt bjf, den broeder aa, van den ende ch. Arthritis Rheumatol. 2018 Sep;70(9):1408-1418. doi: 10.1002/art.40516. Epub 2018 Aug 6. Arthritis Rheumatol. 2018. PMID: 29609207 Clinical Trial.
Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review.
Kelly A, Crimston-Smith L, Tong A, Bartlett SJ, Bekker CL, Christensen R, De Vera MA, de Wit M, Evans V, Gill M, March L, Manera K, Nieuwlaat R, Salmasi S, Scholte-Voshaar M, Singh JA, Sumpton D, Toupin-April K, Tugwell P, van den Bemt B, Verstappen S, Tymms K. Kelly A, et al. J Rheumatol. 2020 Oct 1;47(10):1565-1574. doi: 10.3899/jrheum.190726. Epub 2019 Dec 15. J Rheumatol. 2020. PMID: 31839595
The pharmacological and clinical aspects behind dose loading of biological disease modifying anti-rheumatic drugs (bDMARDs) in auto-immune rheumatic diseases (AIRDs): rationale and systematic narrative review of clinical evidence.
Geurts-Voerman GE, Verhoef LM, van den Bemt BJF, den Broeder AA. Geurts-Voerman GE, et al. Among authors: van den bemt bjf, den broeder aa. BMC Rheumatol. 2020 Jul 28;4:37. doi: 10.1186/s41927-020-00130-x. eCollection 2020. BMC Rheumatol. 2020. PMID: 32743343 Free PMC article.
Patient Perspectives on Outcome Domains of Medication Adherence Trials in Inflammatory Arthritis: An International OMERACT Focus Group Study.
Bekker CL, Bossina S, de Vera MA, Bartlett SJ, de Wit M, March L, Shea B, Evans V, Richards D, Tong A, Tugwell P, Tymms K, Scholte-Voshaar M, Kelly A, van den Bemt BJF. Bekker CL, et al. Among authors: van den bemt bjf. J Rheumatol. 2021 Sep;48(9):1480-1487. doi: 10.3899/jrheum.201568. Epub 2021 May 15. J Rheumatol. 2021. PMID: 33993113
Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare Professionals.
van Lint JA, Jessurun NT, Tas SW, van den Bemt BJF, Nurmohamed MT, van Doorn MBA, Spuls PI, van Tubergen AM, Ten Klooster PM, van Puijenbroek EP, Hoentjen F, Vonkeman HE. van Lint JA, et al. Among authors: van doorn mba, van puijenbroek ep, van tubergen am, van den bemt bjf. J Rheumatol. 2021 Sep;48(9):1388-1394. doi: 10.3899/jrheum.201373. Epub 2021 May 15. J Rheumatol. 2021. PMID: 33993115
193 results